MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202637078888 A) filed by Oyster Point Pharma, Inc. on June 26, 2026, for Aav Vector Encoding Diamine Oxidase And Uses Thereof.
Inventors include Carlson, Eric C.; and Chittester, Dessa.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: Provided are vectors (e.g., recombinant adeno-associated virus, "rAAV" vectors), methods of treating a condition (e.g., a condition associated with excess histamine or histamine-induced inflammation), pharmaceutical compositions, and other compositions and methods, in which the vector comprises a polynucleotide encoding a diamine oxidase ("DAO1"). Methods of treatment may include administration to the salivary glands (e.g., a parotid gland) of a subject.
Disclaimer: Curated by HT Syndication.
